|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
10/2/2012 7:43:45 AM
Scientists have discovered an entirely new class of antibody in camels that is able to cross the blood-brain barrier and diffuse into brain tissue, a find that can improve drug delivery to the brain in Alzheimer's disease. These antibodies, which are naturally available in the camelid family (camels, dromedaries, llamas, and alpacas) may be part of a "game changer" in the outcomes for people with brain diseases, researchers from the US and France believe. "This basic biological investigation opens new pathways toward innovative therapeutic solutions for intractable diseases such as Alzheimer's disease or brain tumours," said Pierre Lafaye, a researcher involved in the work from the Institut Pasteur, PF: Production de Proteines Recombinantes et d'Anticorps -Proteopole in Paris, France.
|
|
|
|
|
|
|
|
|
|
|